Literature DB >> 21743299

MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.

Wen-Bo Li1, Min-Wang Ma, Li-Jie Dong, Fei Wang, Lu-Xia Chen, Xiao-Rong Li.   

Abstract

Aberrant expression of microRNAs (miRNAs) has been implicated in cancer initiation and progression. In this study, we found that microRNA-34a (miR-34a) is significantly downregulated in glioblastoma multiforme (GBM) specimens compared with normal brain tissues. Growth curve and colony formation assays revealed that miR-34a suppresses proliferation of U373MG and SHG44 glioblastoma cells. Overexpression of miR-34a could induce apoptosis of glioblastoma cells. Also, we identified notch1 as a direct target gene of miR-34a. Knockdown of notch1 showed similar cellular functions as overexpression of miR-34a both in vitro and in vivo. Collectively, our findings show that miR-34a is downregulated in GBM cells and inhibits GBM growth by targeting notch1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743299     DOI: 10.4161/cbt.12.6.16300

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  37 in total

1.  Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.

Authors:  Michela Visani; Dario de Biase; Gianluca Marucci; Serenella Cerasoli; Evandro Nigrisoli; Maria Letizia Bacchi Reggiani; Fiorenzo Albani; Agostino Baruzzi; Annalisa Pession
Journal:  Mol Oncol       Date:  2013-12-24       Impact factor: 6.603

2.  Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells.

Authors:  Xiangming Ji; Zhiwei Wang; Andreea Geamanu; Arvind Goja; Fazlul H Sarkar; Smiti V Gupta
Journal:  Int J Cancer       Date:  2012-06-26       Impact factor: 7.396

3.  Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

Authors:  Dejuan Kong; Elisabeth Heath; Wei Chen; Michael Cher; Isaac Powell; Lance Heilbrun; Yiwei Li; Shadan Ali; Seema Sethi; Oudai Hassan; Clara Hwang; Nilesh Gupta; Dhananjay Chitale; Wael A Sakr; Mani Menon; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

4.  MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.

Authors:  Andrej Besse; Jiri Sana; Radek Lakomy; Leos Kren; Pavel Fadrus; Martin Smrcka; Marketa Hermanova; Radim Jancalek; Stefan Reguli; Radim Lipina; Marek Svoboda; Pavel Slampa; Ondrej Slaby
Journal:  Tumour Biol       Date:  2015-12-21

Review 5.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

6.  MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of Notch1.

Authors:  Xiao Yu; Wendi Zhang; Qin Ning; Xiaoping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

7.  Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme.

Authors:  Michael Karsy; Erol Arslan; Fred Moy
Journal:  Genes Cancer       Date:  2012-01

8.  Comprehensive analysis of microRNA expression profile in malignant glioma tissues.

Authors:  Monika Piwecka; Katarzyna Rolle; Agnieszka Belter; Anna Maria Barciszewska; Marek Żywicki; Marcin Michalak; Stanisław Nowak; Mirosława Z Naskręt-Barciszewska; Jan Barciszewski
Journal:  Mol Oncol       Date:  2015-03-25       Impact factor: 6.603

9.  miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.

Authors:  Krishan Jethwa; Jun Wei; Kayla McEnery; Amy B Heimberger
Journal:  Clin Investig (Lond)       Date:  2011-12

10.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.